Evaluation of <i>Quillaja brasiliensis</i> Saponin-Based Nanoparticles Combined with Leucine Aminopeptidases for Immunoprotection of Sheep Against <i>Fasciola hepatica</i>.

Vaccines (Basel) · 2025 · PMC12568199 · PMID 41150396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

When the immune profile through the gene expression of Th1/Th2/Th17/Treg cytokines was analyzed, the Fh LAP1/ Fh LAP2 group showed a trend toward a pro-inflammatory and regulatory profile compared with the Fh LAP1 group after the challenge.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Evaluation of &lt;i&gt;Quillaja brasiliensis&lt;/i&gt; Saponin-Based Nanoparticles Combined with Leucine Aminopeptidases for Immunoprotection of Sheep Against &lt;i&gt;Fasciola hepatica&lt;/i&gt;.

The sentences

Evaluation of <i>Quillaja brasiliensis</i> Saponin-Based Nanoparticles Combined with Leucine Aminopeptidases for Immunoprotection of Sheep Against <i>Fasciola hepatica</i>.